Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aptevo Therapeutics Inc. (APVO)  
$0.13 0.00 (0.00%) as of 4:30 Tue 3/5


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 4,150,000
Market Cap: 537.01(K)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.1294 - $1.81
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Aptevo Therapeutics is a clinical-stage, research and development biotechnology company focused on developing immunotherapeutic candidates for the treatment of different forms of cancer. Co.'s lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using Co.'s ADAPTIR™ modular protein technology platform. Co.'s preclinical candidate APVO442 was developed using its ADAPTIR-FLEX™ modular protein technology platform. The ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of improving the human immune system against cancer cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 128
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gross Jane A See Remarks   •       –      –    2017-08-01 4 OE $0.00 $0 D/D 38,093 78,509     -
   White Marvin L President and CEO   •       •      –    2017-05-22 4 OE $0.00 $0 D/D 53,471 66,332     -
   Gross Jane A See Remarks   •       –      –    2017-03-10 4 D $1.78 $6,830 D/D (3,837) 40,416     -
   Gross Jane A See Remarks   •       –      –    2017-03-10 4 OE $0.00 $0 D/D 14,506 44,253     -
   Stromatt Scott C Chief Medical Officer and SVP   •       –      –    2017-03-10 4 D $1.78 $11,695 D/D (6,570) 69,072     -
   Stromatt Scott C Chief Medical Officer and SVP   •       –      –    2017-03-10 4 OE $0.00 $0 D/D 24,836 75,642     -
   Lamothe Jeffrey G. SVP, CFO and Treasurer   •       –      –    2017-03-10 4 D $1.78 $12,060 D/D (6,775) 41,284     -
   Lamothe Jeffrey G. SVP, CFO and Treasurer   •       –      –    2017-03-10 4 OE $0.00 $0 D/D 18,863 46,274     -
   Gross Jane A See Remarks   •       –      –    2017-03-09 4 D $1.80 $4,631 D/D (2,573) 29,747     -
   Gross Jane A See Remarks   •       –      –    2017-03-09 4 OE $0.00 $0 D/D 9,727 32,320     -
   Stromatt Scott C Chief Medical Officer and SVP   •       –      –    2017-03-09 4 D $1.80 $6,620 D/D (3,678) 50,806     -
   Stromatt Scott C Chief Medical Officer and SVP   •       –      –    2017-03-09 4 OE $0.00 $0 D/D 13,902 54,484     -
   Gross Jane A See Remarks   •       –      –    2017-03-01 4 D $2.02 $4,339 D/D (2,148) 22,593     -
   Gross Jane A See Remarks   •       –      –    2017-03-01 4 OE $0.00 $0 D/D 9,140 25,011     -
   Stromatt Scott C Chief Medical Officer and SVP   •       –      –    2017-03-01 4 D $2.02 $10,730 D/D (5,312) 40,582     -
   Stromatt Scott C Chief Medical Officer and SVP   •       –      –    2017-03-01 4 OE $0.00 $0 D/D 16,269 45,894     -
   Lamothe Jeffrey G. SVP, CFO and Treasurer   •       –      –    2017-03-01 4 OE $0.00 $0 D/D 14,066 29,196     -
   Lamothe Jeffrey G. SVP, CFO and Treasurer   •       –      –    2017-03-01 4 D $2.02 $3,911 D/D (1,936) 22,450     -
   Stromatt Scott C Chief Medical Officer and SVP   •       –      –    2017-02-03 4 OE $0.00 $0 D/D 27,381 29,625     -
   Lamothe Jeffrey G. SVP, CFO and Treasurer   •       –      –    2017-02-03 4 D $1.92 $15,886 D/D (8,274) 17,066     -
   Lamothe Jeffrey G. SVP, CFO and Treasurer   •       –      –    2017-02-03 4 OE $0.00 $0 D/D 25,340 25,340     -
   Gross Jane A See Remarks   •       –      –    2017-02-03 4 D $1.92 $11,370 D/D (5,922) 15,871     -
   Gross Jane A See Remarks   •       –      –    2017-02-03 4 OE $0.00 $0 D/D 18,135 21,793     -
   Emergent Biosolutions Inc. 10% Owner   –       –       •   2016-08-01 4/A D $0.00 $0 D/D (20,229,849) 0     -
   Emergent Biosolutions Inc. 10% Owner   –       –       •   2016-08-01 4 D $0.00 $0 D/D (20,230,074) 0     -
  128 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us